Connect with us

National

New study provides comparative analysis of twelve COVID-19 vaccines – News-Medical.net

A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage…

Published

on

Article feature image

A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020. The study highlights the early successes, as well as the hurdles and barriers yet to be overcome for ending the global COVID-19 pandemic.

  • messenger RNA – Moderna and Pfizer/BioNtech
  • Viral Vector-based (non-replicating) Vaccines – Astra Zeneca/University of Oxford, CanSino Biologics, Gamaleya Research Institute, Johnson…

Click here to view the original article.